COHERUS BIOSCIENCES

coherus-biosciences-logo

Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.
#SimilarOrganizations #People #Financial #Event #Website #More

COHERUS BIOSCIENCES

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Manufacturing Medical Therapeutics

Founded:
2007-01-01

Address:
Redwood City, California, United States

Country:
United States

Website Url:
http://www.coherus.com

Total Employee:
251+

Status:
Active

Contact:
(650) 649-3530

Total Funding:
602.51 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

viragen-logo

Viragen

Viragen researches, develops, manufactures and commercializes therapeutic proteins for the treatment of cancers and viral diseases.


Current Advisors List

mary-szela_image

Mary Szela Director @ Coherus Biosciences
Board_member

mary-szela_image

Mary Szela Board Member @ Coherus Biosciences
Board_member
2014-09-01

not_available_image

Peter Watler Scientific Advisor @ Coherus Biosciences
Advisor

s-edward-torres_image

S. Edward Torres Investor @ Coherus Biosciences
Board_member

mark-stolper_image

Mark Stolper Director Board of Directors @ Coherus Biosciences
Board_member
2021-01-01

Current Employees Featured

not_available_image

Dennis M. Lanfear
Dennis M. Lanfear President, CEO & Chairman @ Coherus Biosciences
President, CEO & Chairman

vincent-r-anicetti_image

Vincent R. Anicetti
Vincent R. Anicetti Chief Operating Officer @ Coherus Biosciences
Chief Operating Officer

not_available_image

Ann M. Lowe
Ann M. Lowe Senior Vice President of Oncology @ Coherus Biosciences
Senior Vice President of Oncology

rebecca-sunshine_image

Rebecca Sunshine
Rebecca Sunshine Senior Vice President, Human Resources @ Coherus Biosciences
Senior Vice President, Human Resources
2014-10-01

michael-fleming_image

Michael Fleming
Michael Fleming Chief Strategy Officer @ Coherus Biosciences
Chief Strategy Officer
2021-01-01

rosh-dias_image

Rosh Dias
Rosh Dias Chief Medical Officer @ Coherus Biosciences
Chief Medical Officer
2022-03-01

not_available_image

Lee Mermelstein
Lee Mermelstein Executive Vice President Manufacturing @ Coherus Biosciences
Executive Vice President Manufacturing
2020-06-01

not_available_image

Vladimir Vexler
Vladimir Vexler Chief Scientific Officer @ Coherus Biosciences
Chief Scientific Officer

erik-d-wiberg_image

Erik D. Wiberg
Erik D. Wiberg Executive Vice President, Corporate Development @ Coherus Biosciences
Executive Vice President, Corporate Development
2017-01-01

paul-reider_image

Paul Reider
Paul Reider Chief Commercial Officer @ Coherus Biosciences
Chief Commercial Officer
2022-01-01

Founder


stephen-c-glover_image

Stephen C. Glover

Stock Details


Company's stock symbol is NASDAQ:CHRS

Acquisitions List

Date Company Article Price
2014-02-12 InteKrin InteKrin acquired by Coherus Biosciences 5 M USD

Investors List

pharmakon-advisors_image

Pharmakon Advisors

Pharmakon Advisors investment in Post-IPO Debt - Coherus Biosciences

shanghai-junshi-biosciences_image

Shanghai Junshi Biosciences

Shanghai Junshi Biosciences investment in Post-IPO Equity - Coherus Biosciences

lord-abbett_image

Lord Abbett

Lord Abbett investment in Post-IPO Equity - Coherus Biosciences

healthcare-royalty-partners_image

HealthCare Royalty Partners

HealthCare Royalty Partners investment in Post-IPO Debt - Coherus Biosciences

kkr_image

Kohlberg Kravis Roberts

Kohlberg Kravis Roberts investment in Series C - Coherus Biosciences

kmg-capital-partners_image

KMG Capital Partners

KMG Capital Partners investment in Series C - Coherus Biosciences

viva-capital-advisors_image

Viva Capital Advisors

Viva Capital Advisors investment in Series C - Coherus Biosciences

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series C - Coherus Biosciences

eight-roads-ventures_image

Eight Roads Ventures

Eight Roads Ventures investment in Series C - Coherus Biosciences

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series C - Coherus Biosciences

Official Site Inspections

http://www.coherus.com Semrush global rank: 2.83 M Semrush visits lastest month: 5.73 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Coherus Biosciences" on Search Engine

dfkcompany.com © 2022. All rights reserved